American Express to acquire TheFork for $700 million to expand European dining network

1 min read     Updated on 15 Jun 2026, 05:18 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

American Express announced a proposed acquisition of TheFork, a leading online restaurant reservation and management platform in Europe, from Tripadvisor for $700 million in cash. The transaction, expected to close before the end of 2026, aims to expand American Express' dining network to approximately 75,000 bookable venues. TheFork connects millions of diners with more than 50,000 restaurants across 11 European countries and will continue to operate under its existing leadership team post-acquisition.

powered bylight_fuzz_icon
43069089

*this image is generated using AI for illustrative purposes only.

American Express announced a proposed acquisition of TheFork, a leading online restaurant reservation and management platform in Europe, from Tripadvisor for $700 million in cash. The transaction is expected to close before the end of 2026, subject to labor consultation and customary conditions, including regulatory approvals. This strategic move aims to expand American Express' dining network to approximately 75,000 bookable venues, strengthening its international business and dining offerings in the region.

TheFork connects millions of diners with more than 50,000 restaurants across 11 European countries through its management, booking, and customer engagement platform. The proposed acquisition builds on American Express' broader dining strategy, following its successful acquisitions of digital dining platforms Resy and Tock. By integrating TheFork, American Express intends to enhance its ability to provide Card Members with access to sought-after restaurants while supporting the growth of its international operations.

Strategic Rationale

Dining is a critical engagement channel for the American Express brand. Rafa Marquez, President of International Card Services at American Express, stated that the acquisition would enrich the company's differentiated Membership Model. He noted that TheFork's strong relationships throughout the European restaurant industry would complement American Express' existing capabilities, allowing Card Members more ways to discover and book great restaurants while helping partners reach more diners.

Almir Ambeskovic, Chief Executive Officer of TheFork, highlighted the alignment of values between the two companies. He emphasized that American Express shares TheFork's commitment to innovation, service, and hospitality. Ambeskovic expressed confidence that the partnership would accelerate TheFork's mission, bringing greater value to restaurants and creating seamless experiences for diners across Europe.

Transaction Details

The following table outlines the key details of the proposed transaction:

Aspect Details
Acquirer American Express
Target TheFork
Seller Tripadvisor
Purchase Price $700 million in cash
Expected Closing Before the end of 2026
Conditions Labor consultation, regulatory approvals

Following the closing of the transaction, TheFork will continue to operate under its existing leadership team. The platform will benefit from the global reach and backing of American Express, which was founded in 1850 and is headquartered in New York. TheFork, founded in 2007, provides restaurants with reservation management, guest engagement, and operational tools to optimize their businesses.

How will American Express integrate TheFork with its existing platforms Resy and Tock to create a cohesive global dining ecosystem?

What specific regulatory hurdles in the 11 European countries could delay the transaction beyond the projected 2026 closing?

Will the acquisition lead to new co-branded card benefits or loyalty rewards specifically tailored for European dining?

like16
dislike

American Express, Eli Lilly, and Live Nation featured on CNBC's Final Trades

1 min read     Updated on 12 Jun 2026, 05:07 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

American Express reported Q1 revenue of $18.91 billion, driven by spending and net interest income. Eli Lilly secured FDA approval for EBGLYSS for atopic dermatitis treatment. Live Nation saw its price target raised to $200 by Morgan Stanley.

powered bylight_fuzz_icon
42809831

*this image is generated using AI for illustrative purposes only.

Jenny Van Leeuwen Harrington, CEO of Gilman Hill Asset Management, LLC, selected American Express Company on CNBC's Halftime Report Final Trades, citing the firm's recent financial performance. American Express reported upbeat first-quarter 2026 results on April 23, with quarterly revenue net of interest expense rising 10% year-over-year to $18.91 billion. This figure surpassed the analyst consensus estimate of $18.62 billion. The growth was driven by higher Card Member spending, increased net interest income, growth in card balances, and strong card fee growth.

Rob Sechan, CEO of NewEdge Wealth, named Eli Lilly and Company as his final trade. This recommendation follows an announcement on June 9 that the U.S. Food and Drug Administration approved the company's EBGLYSS (lebrikizumab-lbkz). The approval covers one maintenance dose every eight weeks for patients with moderate-to-severe atopic dermatitis.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, identified Live Nation Entertainment, Inc. as a stock approaching a new 52-week high. This outlook aligns with a Wednesday update from Morgan Stanley analyst Cameron Mansson-Perrone, who maintained an Overweight rating on the stock and increased the price target from $185 to $200.

Price Action

The following table details the recent stock performance for the highlighted companies:

Company Stock Movement Closing Price
Eli Lilly and Company Gained 2.2% $1,160.95
American Express Company Rose 1.6% $318.49
Live Nation Entertainment, Inc. Climbed 2.9% $172.33

Can American Express sustain its double-digit revenue growth amid potential economic slowdowns and rising credit costs?

How will Eli Lilly's new atopic dermatitis treatment compete in a crowded market against established immunosuppressants?

Will Live Nation Entertainment face increased regulatory scrutiny regarding its dominant market position as it approaches new highs?

like18
dislike